AllergyTalk Episode 30 - Is COVID Vaccine Skin Testing Useful?
Price: FREE for members and non-members
Speakers: Gerald Lee, MD, Stanley Fineman, MD and Anthony Montanaro, MD
Listeners can earn credit by completing the post test questions
AllergyTalk is a podcast designed to provide easy access to research summaries from Allergy Watch and recommendations from subject matter experts in order to bring physicians up to date onthe latest advances in the field of allergy and immunology.
Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
Primary Care Providers
Fellows-in-Training
Learning Objectives
Upon completion of this podcast, learners should be able to:
1. Counsel patients about the importance of carrying multiple epinephrine autoinjectors.
2. Recognize the lack of diagnostic accuracy of excipient skin testing in the evaluation of COVID-19 vaccine reactions.
All identified relevant financial relationships with ineligible companies have been mitigated.
Gerald Lee, MD
No relevant financial relationships with ineligible companies to disclose
Stanley Fineman, MD
Speaker: Takeda
Researcher: Aimmune, DBV, Biocryst
Anthony Montanaro, MD
Researcher: AstraZeneca, Regeneron, Theravance, Teva
Available Credit
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Attendance